Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Albireo Pharma Inc (ALBO)

Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 913,949
  • Shares Outstanding, K 20,701
  • Annual Sales, $ 40,580 K
  • Annual Income, $ -34,030 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.03
  • Price/Sales 14.98
  • Price/Cash Flow N/A
  • Price/Book 8.65
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.69
  • Most Recent Earnings $-1.89 on 11/08/22
  • Next Earnings Date 03/07/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -1.80
  • Number of Estimates 5
  • High Estimate -0.90
  • Low Estimate -2.15
  • Prior Year -0.57
  • Growth Rate Est. (year over year) -215.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.31 +1.95%
on 02/23/23
45.23 -2.39%
on 02/03/23
-0.40 (-0.90%)
since 02/02/23
3-Month
17.78 +148.31%
on 12/27/22
45.23 -2.39%
on 02/03/23
+20.37 (+85.66%)
since 12/02/22
52-Week
16.02 +175.59%
on 09/07/22
45.23 -2.39%
on 02/03/23
+17.33 (+64.62%)
since 03/02/22

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TIG, ALBO, PAYA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TIG : 6.16 (+0.16%)
ALBO : 44.15 (-0.23%)
PAYA : 9.74 (+0.10%)
SHAREHOLDER ALERT: Weiss Law Reminds AQUA, LPTX, CNCE, and ALBO Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

AQUA : 49.88 (+0.95%)
LPTX : 2.60 (+0.39%)
CNCE : 8.37 (+0.12%)
ALBO : 44.15 (-0.23%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALBO, CNCE, AQUA, LPTX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ALBO : 44.15 (-0.23%)
CNCE : 8.37 (+0.12%)
AQUA : 49.88 (+0.95%)
LPTX : 2.60 (+0.39%)
SHAREHOLDER ALERT: Weiss Law Reminds AQUA, LPTX, CNCE, and ALBO Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

AQUA : 49.88 (+0.95%)
LPTX : 2.60 (+0.39%)
CNCE : 8.37 (+0.12%)
ALBO : 44.15 (-0.23%)
ALBIREO PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albireo Pharma, Inc. - ALBO

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Albireo Pharma, Inc. (NasdaqCM: ALBO) to Ipsen...

ALBO : 44.15 (-0.23%)
SHAREHOLDER ALERT: Weiss Law Reminds LPTX, CNCE, ALBO, and CINC Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

LPTX : 2.60 (+0.39%)
CNCE : 8.37 (+0.12%)
ALBO : 44.15 (-0.23%)
CINC : 29.06 (-0.48%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AQUA, CINC, ALBO, PAYA, GMGI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AQUA : 49.88 (+0.95%)
CINC : 29.06 (-0.48%)
ALBO : 44.15 (-0.23%)
PAYA : 9.74 (+0.10%)
GMGI : 2.55 (+1.19%)
Moore Kuehn Encourages GMGI, CINC, ALBO, and PAYA Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

GMGI : 2.55 (+1.19%)
CINC : 29.06 (-0.48%)
ALBO : 44.15 (-0.23%)
PAYA : 9.74 (+0.10%)
SHAREHOLDER ALERT: Weiss Law Reminds ALBO, CINC, DCT, and PAYA Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

ALBO : 44.15 (-0.23%)
CINC : 29.06 (-0.48%)
DCT : 18.99 (unch)
PAYA : 9.74 (+0.10%)
Why These Two Biotech Stocks Blasted Higher This Week

There's nothing like a big-premium buyout to send a company's share price to the moon.

AZN : 63.71 (+0.81%)
IPSEY : 27.8200 (-1.86%)
CINC : 29.06 (-0.48%)
ALBO : 44.15 (-0.23%)

Business Summary

Albireo Pharma, Inc. is a biopharmaceutical company. It focused on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Albireo Pharma Inc., formerly known as BIODEL INC., is based in Boston, United States....

See More

Key Turning Points

3rd Resistance Point 45.61
2nd Resistance Point 45.26
1st Resistance Point 44.70
Last Price 44.15
1st Support Level 43.79
2nd Support Level 43.44
3rd Support Level 42.88

See More

52-Week High 45.23
Last Price 44.15
Fibonacci 61.8% 34.07
Fibonacci 50% 30.63
Fibonacci 38.2% 27.18
52-Week Low 16.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar